Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain

被引:53
作者
Fouillade, Charles [1 ,2 ]
Chabriat, Hugues [3 ]
Riant, Florence [3 ]
Mine, Manuele [3 ]
Arnoud, Minh [1 ,2 ]
Magy, Laurent [4 ]
Bousser, Marie Germaine [3 ]
Tournier-Lasserve, Elisabeth [1 ,2 ,3 ]
Joutel, Anne [1 ,2 ,3 ]
机构
[1] Fac Med Paris 7, INSERM, Site Lariboisiere, U740, F-75010 Paris, France
[2] Univ Paris 07, Fac Med, Site Lariboisiere, F-75010 Paris, France
[3] Groupement Hosp Univ Nord, APHP, Grp Hosp LARIBOISIERE FERNAND WIDAL, Serv Neurol,Lab Genet, F-75010 Paris, France
[4] CHRU Dupuytren, Serv Neurol, F-87042 Limoges, France
关键词
small-vessel-disease of the brain; CADASIL; NOTCH3; heterodimer;
D O I
10.1002/humu.9527
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
The most common causative diagnosis of hereditary small-vessel-disease of the brain, CADASIL, is due to highly stereotyped mutations in the NOTCH3 receptor. NOTCH3 has 33 exons but all CADASIL mutations occur within the Epidermal Growth Factor-like Repeats encoded by exons 2-24, lead to an odd number of cysteine residues and are associated with GOM deposits and abnormal NOTCH3 protein accumulation. The majority of CADASIL mutations appear to retain normal level of signaling activity, while very few mutations show reduced activity. Herein we identified a novel heterozygous missense mutation (c.4544T > C in exon 25 of NOTCH3 in a patient with cerebral small-vessel-disease but lacking GOM deposits and NOTCH3 accumulation. The mutation should result in a p.L1515P substitution in the evolutionarily highly conserved juxtamembranous region of NOTCH3, which constitutes the heterodimerization domain. The p.L1515P mutant exhibits increased canonical NOTCH3 signaling, although in a ligand-independent fashion. Biochemical analysis suggests that the mutation renders NOTCH3 hyperactive through destabilization of the heterodimer. Therefore, our study suggests that the p.L1515P mutation falls in a novel mechanistic class of NOTCH3 mutations and that NOTCH3 activating mutations should be further considered for molecular analysis of patients with cerebral small-vessel-disease. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:452 / 452
页数:1
相关论文
empty
未找到相关数据